Your browser doesn't support javascript.
loading
Once-daily, single-inhaler mometasone-indacaterol-glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone-salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study.
Kerstjens, Huib A M; Maspero, Jorge; Chapman, Kenneth R; van Zyl-Smit, Richard N; Hosoe, Motoi; Tanase, Ana-Maria; Lavecchia, Catherine; Pethe, Abhijit; Shu, Xu; D'Andrea, Peter.
Afiliação
  • Kerstjens HAM; Department of Pulmonology, University of Groningen, University Medical Center Groningen, and Groningen Research Institute for Asthma and COPD, Groningen, Netherlands. Electronic address: h.a.m.kerstjens@umcg.nl.
  • Maspero J; Allergy and Respiratory Research Unit, Fundación Centro Investigacion de Enfermedades Alergicas y Respiratorias, Buenos Aires, Argentina.
  • Chapman KR; Division of Respiratory Medicine, Department of Medicine, University of Toronto, Toronto, ON, Canada.
  • van Zyl-Smit RN; Division of Pulmonology and UCT Lung Institute, University of Cape Town, Cape Town, South Africa.
  • Hosoe M; Novartis Pharma, Basel, Switzerland.
  • Tanase AM; Novartis Pharma, Basel, Switzerland.
  • Lavecchia C; Novartis Pharmaceuticals, East Hanover, NJ, USA.
  • Pethe A; Novartis Pharmaceuticals, East Hanover, NJ, USA.
  • Shu X; Novartis Pharmaceuticals, East Hanover, NJ, USA.
  • D'Andrea P; Novartis Pharmaceuticals, East Hanover, NJ, USA.
Lancet Respir Med ; 8(10): 1000-1012, 2020 10.
Article em En | MEDLINE | ID: mdl-32653074
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Asma / Quinolonas / Combinação Fluticasona-Salmeterol / Furoato de Mometasona / Glicopirrolato / Indanos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Respir Med Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Asma / Quinolonas / Combinação Fluticasona-Salmeterol / Furoato de Mometasona / Glicopirrolato / Indanos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Respir Med Ano de publicação: 2020 Tipo de documento: Article